➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School

Last Updated: June 18, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Bitopertin

Email this page to a colleague

« Back to Dashboard

What is the drug development status for Bitopertin?

Bitopertin is an investigational drug.

There have been 10 clinical trials for Bitopertin. The most recent clinical trial was a Phase 3 trial, which was initiated on December 1st 2010.

The most common disease conditions in clinical trials are Schizophrenia, Disease, and Compulsive Personality Disorder. The leading clinical trial sponsors are Hoffmann-La Roche, Niuvanniemi Hospital, and Karolinska Institutet.

Recent Clinical Trials for Bitopertin
A Study of Bitopertin (RO4917838) in Adults With Non-Transfusion-Dependent Beta-ThalassemiaHoffmann-La RochePhase 2
A Study Exmining the Effect of Multiple Doses of Bitopertin on the Single Dose Pharmacokinetics of Midazolam in Healthy Volunteers.Hoffmann-La RochePhase 1
Sodium Benzoate for Treatment of Attenuated/Transient Psychosis. A Randomized Placebo-controlled Trial.Karolinska InstitutetPhase 2

See all Bitopertin clinical trials

Clinical Trial Summary for Bitopertin

Top disease conditions for Bitopertin
Top clinical trial sponsors for Bitopertin

See all Bitopertin clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.